Gestational diabetes & diabetes in pregnancy

Adherence to diabetes screening recommendations 4.5 years after birth in women with gestational diabetes managed with tight or less tight glycaemic targets

Diabetes Res Clin PractPublished Follow-up study of the TARGET randomised trial

Authors' conclusion

Adherence to recommended diabetes screening after GDM was low, with women allocated to tight compared with less tight glycaemic targets having higher adherence. Future research should investigate how to modify care for women with GDM to encourage diabetes screening after birth.

Study context

Population
Women with gestational diabetes mellitus (GDM) who consented to the TARGET 4.5 Year Follow-Up; data from hospital records, community laboratories, general practice records and a maternal health questionnaire
Participants
314 women
Comparison
Tight vs less tight glycaemic targets in pregnancy
  • Tight targetsn = 162
  • Less tight targetsn = 152reference
Primary endpoint
Adherence to recommended diabetes screening after birth
Follow-up
4.5 years after birth
Methodological details4.5-year follow-up
  • 4.5-year follow-up

Primary result

As reported in the abstract

Mean overall adherence to diabetes screening

Mean overall adherence to diabetes screening

46.9%

95% CI 43.8 to 50.0

Further findings

High overall adherence to screening (≥75% of recommended HbA1c measurements)

P = 0.02

Cardiometabolic outcomes by screening adherence

Metabolic syndrome and class 2 obesity detected more often with high than low screening adherence

Predictors of low adherence

No independent predictors for low adherence identified

Original publication

Adherence to diabetes screening recommendations 4.5 years after birth in women with gestational diabetes managed with tight or less tight glycaemic targets. Diabetes Res Clin Pract. Published 14 March 2026. doi:10.1016/j.diabres.2026.113213

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.